Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Melanotan-I

Afamelanotide, MT-I, [Nle4-D-Phe7]-α-MSH, Scenesse, CUV-1647

Quick Stats
Studies 225
Trials 100
Score 3
2003 pubmed 14 citations

Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.

Joseph. Christine G CG; Wilczynski. Andrzej A; Holder. Jerry R JR; Xiang. Zhimin Z; Bauzo. Rayna M RM; Scott. Joseph W JW; Haskell-Luevano. Carrie C

Key Findings

  • Replacing the DPhe‑Arg‑Trp segment of NDP‑MSH with the AGRP Arg‑Phe‑Phe sequence still produced agonist activity at mouse melanocortin receptors.
  • One chimeric peptide (Ac‑Ser‑Tyr‑Ser‑Nle4‑Glu‑His‑Arg‑DPhe‑Phe‑Gly‑Lys‑Pro‑Val‑NH2) showed 7 nM potency at MC1R and >800‑fold selectivity over MC3R and >2000‑fold over MC4R.
  • The results suggest the AGRP Arg‑Phe‑Phe motif can mimic the agonist Phe‑Arg‑Trp interactions, offering a new template for designing highly MC1R‑selective ligands.

Practical Outcomes

  • For biohackers, this work hints that future tanning peptides could be engineered to target MC1R almost exclusively, potentially reducing side‑effects like appetite changes linked to MC3/4 activation. However, the data are from mouse receptors and early‑stage peptide designs, so no immediate protocol changes are possible yet.

Summary

Scientists swapped parts of a known tanning peptide (NDP‑MSH) with pieces from a protein that normally blocks the same receptors. Surprisingly, the new hybrid still activated the receptors in mice, and one version was extremely good at hitting only the MC1R receptor, which is the one that makes skin tan, while ignoring the other receptors that affect appetite and metabolism.

Abstract

Agouti-related protein (AGRP) is one of only two known endogenous antagonists of G-protein coupled receptors (GPCRs). Specifically, AGRP antagonizes the brain melanocortin-3 and -4 receptors involved in energy homeostasis, regulation of feeding behavior, and obesity. Alpha-melanocyte stimulating hormone (alpha-MSH) is one of the known endogenous agonists for these receptors. It has been hypothesized that the Arg-Phe-Phe (111-113) human AGRP amino acids may be mimicking the melanocortin agonist Phe-Arg-Trp (7-9) residue interactions with the melanocortin receptors that are important for both receptor molecular recognition and stimulation. To test this hypothesis, we generated thirteen chimeric peptide ligands based upon the melanocortin agonist peptides NDP-MSH (Ac-Ser-Tyr-Ser-Nle4-Glu-His-DPhe-Arg-Trp-Gly-Lys-Pro-Val-NH2) and MTII (Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2). In these chimeric ligands, the agonist DPhe-Arg-Trp amino acids were replaced by the AGRP Arg-Phe-Phe residues, and resulted in agonist activity at the mouse melanocortin receptors (mMC1R and mMC3-5Rs), supporting the hypothesis that the AGRP antagonist ligand Arg-Phe-Phe residues mimic the agonist Phe-Arg-Trp amino acids. Interestingly, the Ac-Ser-Tyr-Ser-Nle4-Glu-His-Arg-DPhe-Phe-Gly-Lys-Pro-Val-NH2 peptide possessed 7 nM mMC1R agonist potency, and is 850-fold selective for the mMC1R versus the mMC3R, 2300-fold selective for the mMC1R versus the mMC4R, and 60-fold selective for the MC1R versus the mMC5R, resulting in the discovery of a new peptide template for the design of melanocortin receptor selective ligands.

Study Information

Provider

pubmed

Year

2003

Date

2003-12-01T00:00:00.000Z

DOI

10.1016/j.peptides.2003.10.005

Citations

14

References

58